Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Tight controls and focus on innovation provide strong outlook for Roche

This article was originally published in Scrip

Executive Summary

Taking Roche on the road to present its financial results is developing into a habit for CEO Severin Schwan, who brought his top team to London again on July 23rd to unveil another impressive performance from the world’s number five in pharma in ex-factory sales and clear number one in diagnostics.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC003800

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel